CAS: 1131626-47-5
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Gamitrinib TPP hexafluorophosphate REF: IN-DA01EO4XCAS: 1131626-47-5 | 99% | A consultar | Mar 10 Dic 24 |
 | Gamitrinib TPP hexafluorophosphate REF: TM-T11356CAS: 1131626-47-5 | 98.52% - 98.52% | A consultar | Mar 10 Dic 24 |
 | Gamitrinib-TPP REF: 3D-GVB62647CAS: 1131626-47-5 | Min. 95% | A consultar | Vie 17 Ene 25 |
Gamitrinib TPP hexafluorophosphate
CAS:1131626-47-5
Fórmula:
C52H65F6N3O8P2
Pureza:
99%
Peso molecular:
1036.0257
Ref: IN-DA01EO4X
| 1mg | 619,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
Gamitrinib TPP hexafluorophosphate
CAS:1131626-47-5
Gamitrinib TPP hexafluorophosphate is a mitochondrial-targeted HSP90 inhibitor with anticancer activity that can be used …
Fórmula:
C52H65F6N3O8P2
Pureza:
98.52% - 98.52%
Forma y color:
Solid
Peso molecular:
1036.03
Ref: TM-T11356
| 1mg | 545,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
Gamitrinib-TPP
CAS:1131626-47-5
Gamitrinib-TPP is a synthetic drug that was developed to target cancer cells. It has been …
Fórmula:
C53H67F6N3O8P2
Pureza:
Min. 95%
Peso molecular:
1,050.05 g/mol
Ref: 3D-GVB62647
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 17 de Enero de 2025
